Shenzhen Chipscreen Biosciences Co., Ltd.

XSSC:688321 Rapporto sulle azioni

Cap. di mercato: CN¥9.4b

Shenzhen Chipscreen Biosciences Salute del bilancio

Salute finanziaria criteri di controllo 1/6

Shenzhen Chipscreen Biosciences has a total shareholder equity of CN¥1.6B and total debt of CN¥1.3B, which brings its debt-to-equity ratio to 78.4%. Its total assets and total liabilities are CN¥3.3B and CN¥1.7B respectively.

Informazioni chiave

78.4%

Rapporto debito/patrimonio netto

CN¥1.29b

Debito

Indice di copertura degli interessin/a
ContantiCN¥481.76m
Patrimonio nettoCN¥1.64b
Totale passivitàCN¥1.69b
Totale attivitàCN¥3.34b

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

Analisi della posizione finanziaria

Passività a breve termine: 688321's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥380.4M).

Passività a lungo termine: 688321's short term assets (CN¥1.1B) do not cover its long term liabilities (CN¥1.3B).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 688321's net debt to equity ratio (49.1%) is considered high.

Riduzione del debito: 688321's debt to equity ratio has increased from 6.9% to 78.4% over the past 5 years.

Copertura del debito: 688321's debt is not well covered by operating cash flow (2.3%).

Copertura degli interessi: Insufficient data to determine if 688321's interest payments on its debt are well covered by EBIT.


Bilancio


Scoprire le aziende sane